Join us at the 2023 ASCO Annual Meeting (booth #10005) to discover how we are harnessing the power of data, technology and connected insights to unlock new possibilities for better cancer care.
We’re excited to meet with you!
Every patient with cancer deserves timely, personalized care. Yet common challenges like staff shortages, administrative burdens, and data silos can hinder your ability to deliver personalized care to all patients.
At Roche, we aim to create a more connected, secure and efficient healthcare system, where digital solutions clarify navigation throughout the oncology care continuum, unlocking new possibilities for better cancer care.
Our Oncology portfolio is designed to redefine the way cancer care is delivered across the patient’s entire care journey. From early detection and accurate diagnosis, to personalized treatment planning and follow-up care, our intuitive and intelligent software solutions provide actionable data and meaningful insights, helping you make the best decisions for each patient at each point in care, while maximizing clinical and operational efficiencies for your organization.
What if you could simplify clinical judgment with automated, supported decision making? Algorithm Suite is a software solution that gathers high value certified algorithms that help make clinical decisions and guide clinical workflows, all in one unique access point.
Make fragmented patient data and fragmented care a thing of the past with Oncology Hub. This cloud-based clinical workflow and decision support solution provides clinicians with the right information at the right time, through a holistic view of the patient’s journey, so that making the right decision is easy.
Without the support of a digital platform, tumor boards can be labor intensive and add additional administrative burdens. Tumor Board enables multidisciplinary oncology care teams to work together more effectively. Schedule meetings more easily. Conveniently and securely access, review, and share pertinent patient data across the network. Track and report accreditation analytics. Have clear sight into guidelines and available clinical trials. And—most importantly—quickly arrive at the best care plan for each patient.
Mutation Profiler enables confident, clear and efficient interpretation of mutation in tumors and provides current potential personalized treatment and clinical trial options in a concise, professional report. With a user-friendly interface, this solution offers three times more reports per hour and has been shown to reduce time to report for NGS data analysis by 65-75%
With so many decisions resting on pathology findings, Digital Pathology is a customisable software platform that enhances the efficiency of the pathology workflow with laboratory integration and automation. It connects pathologists for instant collaboration and drives innovation with Roche image analysis algorithms and integration with partner image analysis algorithms and AI tools.
Visit Roche at ASCO23 | Booth 10005
Thank you. Our team will be in touch soon.
References & notes
* navify Mutation Profiler and navify Digital Pathology are CE-IVD. In the US, navify Mutation Profiler and navify Digital Pathology are for Research Use Only (RUO). Not for use in diagnostic procedures or decisions.
Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050
Open digital ecosystems: Accelerating access to innovation through collaboration...
